Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.67K Sell
70
-26
-27% -$1.38K ﹤0.01% 856
2026
Q1
$5.3K Buy
+96
New +$5.2K ﹤0.01% 676
2025
Q4
Sell
-575
Closed -$24.8K 530
2025
Q3
$24.8K Buy
+575
New +$22.5K 0.01% 368
2024
Q1
Sell
-30,461
Closed -$1.13M 116
2023
Q4
$1.13M Buy
+30,461
New +$1.09M 0.81% 61

Other funds holding GSK

JPL Wealth Management's GSK Position: Q2 2026 in Review

JPL Wealth Management reduced its GSK (GSK) stake by 27% in Q2 2026, selling an estimated $1.38K and leaving 70 shares worth $3.67K. The position accounts for ﹤0.01% of the portfolio, ranked #856.

JPL Wealth Management first reported a position in GSK in Q4 2023 and has held it in 4 quarters since. The position peaked at $1.13M in Q4 2023. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • JPL Wealth Management held 70 shares of GSK worth $3.67K as of Q2 2026.
  • JPL Wealth Management sold 26 GSK shares in Q2 2026, an estimated $1.38K.
  • GSK made up ﹤0.01% of JPL Wealth Management's portfolio in Q2 2026, its #856 holding.
  • JPL Wealth Management first reported a position in GSK in Q4 2023 and has held it in 4 quarters since.
  • JPL Wealth Management's GSK position peaked at $1.13M in Q4 2023.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.